Merck allocates three million courses of Molnupiravir to be provided in first half of 2022 for use in LMICs Read more
Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients Read more
IIT Mandi researchers discover phytochemicals in Himalayan plant that inhibit COVID-19 virus Read more